We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedx Pharma Share News (REDX)

Share Price Information for Redx Pharma (REDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 8.00
Ask: 10.00
Change: -1.00 (-10.00%)
Spread: 2.00 (25.00%)
Open: 9.00
High: 9.00
Low: 8.25
Prev. Close: 10.00
REDX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

Mon, 18th May 2020 14:39

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

FastForward Innovations Ltd - growth company investment - Lorne Abony steps down as chair and chief executive officer to "pursue his other business interests" but will serve as non-executive director of investee Yooma Corp. Abony also will monitor FastForward's interests in EMMAC Life Sciences, Vemo Education and Leap Gaming. FastForward said Monday it has agreed to invest USD1 million in Yooma as part of a USD5 million fundraising round. It has a 10.65% stake in Yooma with a value of USD2.3 million based on the fundraising round pricing. Yooma intends to partner with Asian social and e-commerce platforms to create a hemp and cannabidiol-focused lifestyle company. FastForward named non-executive directors Ed McDermott and Ian Burns as CEO and non-executive chair, respectively.

----------

Coats Group PLC - industrial thread maker - Hires Victrex PLC Chief Executive Officer Jakob Sigurdsson as non-executive director from October 1. Victrex is a FTSE 250-listed polymers firm.

----------

Redx Pharma PLC - cancer and fibrosis drugs - Hires Sarah Wild as independent non-executive director, from July 1. Wild was senior healthcare analyst at Lone Pine Capital LLC. Currently non-executive director at Oxford Nanopore Technologies and Evox Therapeutics.

----------

Advanced Medical Solutions Group PLC - wound dressings - Non-Executive Director Peter Steinmann to retire from board at June 10 annual general meeting. The company said the departure is part of its plan to refresh the non-executive directors on the board, and it is in the process of finding a replacement.

----------

React Group PLC - deep cleaning and decontamination - Promotes Andrea Pankhurst to board as chief financial officer. Pankhurst has been finance director of React Specialist Cleaning Ltd, React's operating subsidiary, since January.

----------

Victoria Oil & Gas PLC - gas producer in Cameroon - Andrew Diamond resigns as finance director and from company. Will step down from board immediately but help with the handover to a new finance director during his six-month notice period.

----------

Staffline Group PLC - recruitment and training - Promotes Interim CFO Daniel Quint to board as executive director from Monday. Quint remains interim CFO.

----------

Maestrano Group PLC - transport analytics - Hires Nicholas Wayne as vice president for the Americas. Wayne was a senior executive with Airbus SE in North America, working in its intelligence business. He was a founder of Airbus Aerial, which drew insights from satellite, airplane and drone imagery.

----------

San Leon Energy PLC - Nigeria oil & gas exploration and production - Bill Higgs steps down as non-executive director immediately, after serving two years.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
11 Mar 2020 10:23

Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses

Redx Pharma Optimistic As Loss Narrows And Cancer Trial Progresses

Read more
28 Feb 2020 18:47

UPDATE: Redx Pharma To Get GBP26 Million Injection Amid No Yesod Bid

UPDATE: Redx Pharma To Get GBP26 Million Injection Amid No Yesod Bid

Read more
28 Feb 2020 18:08

No Redx Pharma Takeover As Yesod Opts Not To Make Offer

No Redx Pharma Takeover As Yesod Opts Not To Make Offer

Read more
14 Feb 2020 17:11

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

Read more
28 Jan 2020 14:15

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

UK Regulator Extends Deadline For Possible Redx Pharma Cash Offer

Read more
24 Jan 2020 11:51

Moulton Goodies Raises Stake In Redx Pharma To 42% From 18%

Moulton Goodies Raises Stake In Redx Pharma To 42% From 18%

Read more
9 Jan 2020 16:02

Redx Pharma nominates next drug development candidate

(Sharecast News) - Drug discovery and development company Redx Pharma announced the nomination of RXC007 as its next drug development candidate for the treatment of fibrosis on Thursday.

Read more
9 Jan 2020 11:17

Redx Pharma Nominates Another Anti-Fibrosis Drug Candidate

Redx Pharma Nominates Another Anti-Fibrosis Drug Candidate

Read more
31 Dec 2019 10:34

UK WINNERS & LOSERS SUMMARY: Redx Surges On Potential Takeover Offer

UK WINNERS & LOSERS SUMMARY: Redx Surges On Potential Takeover Offer

Read more
31 Dec 2019 09:12

Redx Pharma Shares Soar On Discussions Over Possible Takeover Offer

Redx Pharma Shares Soar On Discussions Over Possible Takeover Offer

Read more
31 Dec 2019 08:51

LONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking

LONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking

Read more
19 Nov 2019 12:29

Redx collaboration with MDC awarded Innovate UK funding

(Sharecast News) - Redx Pharma announced on Tuesday that Innovate UK has awarded biomedical catalyst funding to Redx and Medicines Discovery Catapult (MCD).

Read more
19 Nov 2019 11:53

Redx Pharma Secures Funding To Develop Lung Condition Therapies

Redx Pharma Secures Funding To Develop Lung Condition Therapies

Read more
19 Aug 2019 10:22

Redx Pharma Gets Approval To Escalate Dose In RXC004 Study

(Alliance News) - Redx Pharma PLC on Monday said it has successfully completed dosing of the first cohort of patients in its ongoing phase 1/2 study with RXC004.RXC004 is an oral porcupine

Read more
19 Aug 2019 09:43

Redx Pharma gets green light to escalate dose in RXC004 study

(Sharecast News) - Drug discovery and development company Redx Pharma has successfully completed dosing of the first cohort of patients in its ongoing phase 1 and 2 study with 'RXC004', it announced on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.